查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945831

免疫力增强产品市场－全球产业规模、份额、趋势、机会及预测（按类型、通路、地区及竞争格局划分，2021-2031年）

Immunity Boosting Products Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Distribution Channel, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球免疫增强产品市场预计将从 2025 年的 311.6 亿美元成长到 2031 年的 481.4 亿美元，复合年增长率为 7.52%。

这些产品包括膳食补充剂、机能性食品和饮料，其中添加了维生素、矿物质、益生菌和植物萃取物等活性成分，旨在增强人体免疫系统。市场成长的关键驱动因素是消费行为向健康保健方向的结构性转变，人们越来越重视长期健康维护和疾病预防，而非被动治疗。全球人口老化和人们对营养缺乏的日益关注进一步支撑了这种持续的需求，确保该品类全年保持旺盛的市场地位。例如，根据责任营养委员会 (CRN) 2024 年发布的报告，30% 的膳食补充剂消费者表示，增强免疫力是他们服用这些产品的主要动机，这凸显了该行业的持续活力。

市场概览
预测期 2027-2031
市场规模：2025年 311.6亿美元
市场规模：2031年 481.4亿美元
复合年增长率：2026-2031年 7.52%
成长最快的细分市场 补充
最大的市场 北美洲

儘管全球免疫增强产品市场呈现积极的成长趋势，但由于各国监管法规的零碎化，该市场仍面临许多挑战。在健康声明、成分安全标准和标籤要求等方面，标准的不一致给寻求全球扩张的製造商设置了重重障碍。这种监管上的不一致往往迫使企业针对特定市场定製配方，从而增加生产成本，降低供应链效率，阻碍市场快速扩张。

市场驱动因素

全球免疫增强产品市场的主要驱动力是消费者对医疗保健和健康维护日益增长的兴趣。这从根本上改变了人们的购买习惯，从季节性应对转向日常主动管理。人们越来越意识到持续免疫力与长寿之间的联繫，促使他们将免疫支持产品融入日常生活。近期消费者意识调查也印证了这个趋势。协和发酵工业株式会社于2024年9月发布的《2024年及以后的免疫健康》报告显示，51%的消费者比两年前更加关注自体免疫健康。这种日益增长的关注和重视程度的提高，推动了对能够提供持续保护而非暂时缓解的膳食补充剂和功能性产品的稳定需求。

此外，市场成长也受到消费者对天然、有机和植物来源成分需求激增的推动。消费者越来越注重标籤上经过科学检验的纯净成分，这为关键免疫调节成分的供应链带来了显着的偏好。根据全球EPA和DHA Omega-3 3组织于2024年9月发布的《2024年全球EPA和DHA Omega-3-3成分市场报告》，全球Omega-3成分市场预计在2023年将增长22.5%，这反映了成本上升和优质化趋势。此外，国际益生菌协会（IPA）预测，亚太地区益生菌补充剂的销售额将在2024年至2028年期间维持9.2%的年增长率，这印证了该地区对天然免疫解决方案的强劲需求。

市场挑战

国际监管体系的分散化仍是限制全球免疫增强产品市场成长的一大障碍。製造商面临不同的健康声明和成分安全标准，这阻碍了他们有效利用规模经济。这种情况迫使企业开发相同产品的多种变体以符合相互衝突的当地法律，这不可避免地增加了生产成本并使供应链物流更加复杂。因此，与合规、重新贴标和配方调整相关的巨额成本占用了原本可以投入研发和市场开发的资金。

这种碎片化的监管环境阻碍了企业进入新市场的能力，并造成了营运摩擦。当分散化发生在单一主要市场内部时，这种复杂性会进一步加剧，为本已复杂的市场环境增添新的难度。例如，根据天然产品协会 (NPA) 2024 年的报告，已有 13 个州表示有意考虑建立州级法规结构，这有可能用一系列地方性法规取代统一的联邦框架。这种监管的不确定性迫使企业采取谨慎的分阶段扩张策略，而不是实施激进的全球策略。

市场趋势

随着消费者越来越意识到心理健康与免疫力之间的心理生物学联繫，免疫功能与压力和睡眠支持的融合正在迅速发展。消费者不再孤立地关注单一健康要素，而是越来越倾向于透过整体疗法来优化他们的健康习惯，从而同时管理焦虑、睡眠不足和增强免疫力。这种对多功能解决方案的需求得到了数据的支持，这些数据显示了人们健康优先事项的转变。根据报导-Firmenich于2024年12月发布的《健康生活：最新全球消费者洞察》报告，心理和情绪健康（48%）以及免疫力（44%）同时被列为最重要的健康问题，这推动了结合免疫调节剂、适应原和放鬆成分的混合产品的开发。

同时，市场正积极推动将免疫益处融入机能性食品和饮料，使该品类摆脱传统的药品形式。为了应对“服药疲劳”，生产商正在零食、优格和果汁等日常消费品中添加增强免疫力的成分，使健康管理成为日常营养的自然组成部分，而非一项医疗任务。这种朝向生活方式导向产品的拓展，主要受消费者需求的驱动。根据协和发酵工业株式会社于2024年9月发布的《2024年后的免疫健康》报告，74%的膳食补充剂消费者表示会考虑食用有助于增强免疫力的食品和饮料，这充分证明了向强化功能性营养的战略转变是合理的。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球免疫力增强产品市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 按类型（补充剂、饮料、食品、其他）
    • 按分销管道（超级市场/大卖场、便利商店、药局、线上）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章 北美免疫力产品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国家分析
    • 我们
    • 加拿大
    • 墨西哥

7. 欧洲免疫力产品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章 亚太地区免疫力增强产品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章 中东和非洲免疫力增强产品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲：国家分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章 南美洲免疫力提升产品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 司机
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 最新进展

第十三章 全球免疫力增强产品市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的可能性
  • 供应商电力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Amway Corporation
  • Herbalife Nutrition Ltd.
  • Nestle SA
  • Pfizer Inc.
  • Bayer AG
  • NOW Foods
  • Nature's Bounty Co.
  • GNC Holdings, Inc.
  • Himalaya Drug Company
  • Glanbia plc

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 5038

The Global Immunity Boosting Products Market is projected to expand from USD 31.16 Billion in 2025 to USD 48.14 Billion by 2031, progressing at a CAGR of 7.52%. These products encompass dietary supplements, functional foods, and beverages fortified with active ingredients like vitamins, minerals, probiotics, and botanicals designed to strengthen the human immune system. Market growth is primarily driven by a structural transition in consumer behavior toward preventive healthcare, where individuals prioritize long-term wellness and disease avoidance over reactive medical treatments. This sustained demand is further supported by an aging global population and increased awareness of nutritional deficiencies, ensuring the category remains relevant throughout the year. For instance, the Council for Responsible Nutrition reported in 2024 that 30 percent of dietary supplement users identified immune health as a leading motivation for their regimen, highlighting the sector's enduring vitality.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 31.16 Billion
Market Size 2031USD 48.14 Billion
CAGR 2026-20317.52%
Fastest Growing SegmentSupplement
Largest MarketNorth America

Despite these positive growth trajectories, the Global Immunity Boosting Products Market encounters a substantial challenge due to regulatory fragmentation across various international jurisdictions. Inconsistent standards regarding permissible health claims, ingredient safety thresholds, and labeling requirements establish complex barriers for manufacturers seeking to scale operations globally. This regulatory disparity frequently compels companies to customize formulations for specific markets, leading to escalated production costs and supply chain inefficiencies that can hinder rapid market expansion.

Market Driver

A primary catalyst for the Global Immunity Boosting Products Market is the increasing consumer emphasis on preventive healthcare and wellness, which is fundamentally shifting purchasing habits from seasonal reactivity to proactive daily management. As individuals become more aware of the connection between immune resilience and overall longevity, they are incorporating immunity-supporting products into their everyday routines. This trend is substantiated by recent consumer sentiment; according to the 'Immune Health in 2024 and Beyond' report by Kyowa Hakko in September 2024, 51 percent of consumers expressed greater concern about their immune health compared to two years prior. This elevated anxiety and prioritization drive consistent demand for supplements and functional products that provide continuous defense rather than temporary relief.

Furthermore, the market is propelled by surging demand for natural, organic, and plant-based ingredients, as consumers increasingly examine labels for clean, scientifically validated components. This preference is generating significant economic activity within the supply chain for key immune-modulating raw materials. As noted in the '2024 Global EPA and DHA Omega-3 Ingredient Market Report' by the Global Organization for EPA and DHA Omega-3s in September 2024, the value of the global omega-3 ingredient market rose by 22.5 percent in 2023, reflecting rising costs and premiumization. Additionally, the International Probiotics Association projected in 2024 that probiotic supplement sales in the Asia Pacific region would maintain a 9.2 percent growth rate through 2028, underscoring strong regional momentum for natural immune solutions.

Market Challenge

Regulatory fragmentation across international jurisdictions remains a significant barrier restricting the growth of the Global Immunity Boosting Products Market. Manufacturers facing divergent standards regarding permissible health claims and ingredient safety limits are unable to effectively leverage economies of scale. This situation forces companies to develop multiple variations of the same product to comply with conflicting local laws, inevitably increasing production costs and complicating supply chain logistics. Consequently, financial resources that could be invested in research and market development are instead consumed by the substantial costs associated with compliance, relabeling, and reformulation.

The impact of this disjointed regulatory environment hampers the speed at which companies can enter new territories and creates operational friction. This complexity is intensified when fragmentation occurs even within single key markets, adding further layers of difficulty to an already intricate landscape. For example, the Natural Products Association reported in 2024 that 13 states demonstrated a willingness to consider creating state-level regulatory schemes, threatening to replace unified federal frameworks with a patchwork of local mandates. Such regulatory volatility compels businesses to adopt a cautious, piecemeal approach to expansion rather than executing aggressive global strategies.

Market Trends

The convergence of immunity with stress and sleep support is rapidly advancing as consumers increasingly acknowledge the psychobiological connection between mental well-being and immune resilience. Rather than addressing these health aspects in isolation, individuals are seeking holistic formulations that simultaneously manage anxiety, sleep deprivation, and immune defense, thereby optimizing their wellness regimens. This demand for multi-functional solutions is supported by data on shifting health priorities; according to the 'Health expectancy: Latest global consumer insights' article by DSM-Firmenich in December 2024, mental and emotional health (48 percent) and immunity (44 percent) were identified as top concurrent health concerns, driving the development of hybrid products combining immune-modulators with adaptogens and relaxants.

Simultaneously, the market is seeing a decisive integration of immune benefits into functional foods and beverages, shifting the category away from traditional pharmaceutical-like formats. Manufacturers are addressing "pill fatigue" by fortifying everyday consumables-such as snacks, yogurts, and juices-with immune-supporting ingredients, making health management a seamless part of daily nutrition rather than a medical task. This expansion into lifestyle-oriented formats is strongly supported by consumer interest; according to the 'Immune Health in 2024 and Beyond' report by Kyowa Hakko in September 2024, 74 percent of supplement consumers indicated they would consider foods and beverages to support their immune health, validating the strategic pivot toward fortified functional nutrition.

Key Market Players

  • Amway Corporation
  • Herbalife Nutrition Ltd.
  • Nestle S.A.
  • Pfizer Inc.
  • Bayer AG
  • NOW Foods
  • Nature's Bounty Co.
  • GNC Holdings, Inc.
  • Himalaya Drug Company
  • Glanbia plc

Report Scope

In this report, the Global Immunity Boosting Products Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Immunity Boosting Products Market, By Type

  • Supplement
  • Beverages
  • Food
  • Others

Immunity Boosting Products Market, By Distribution Channel

  • Supermarket/Hypermarkets
  • Convenience Stores
  • Medical Stores
  • Online

Immunity Boosting Products Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Immunity Boosting Products Market.

Available Customizations:

Global Immunity Boosting Products Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Immunity Boosting Products Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Supplement, Beverages, Food, Others)
    • 5.2.2. By Distribution Channel (Supermarket/Hypermarkets, Convenience Stores, Medical Stores, Online)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Immunity Boosting Products Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Distribution Channel
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Immunity Boosting Products Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Distribution Channel
    • 6.3.2. Canada Immunity Boosting Products Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Distribution Channel
    • 6.3.3. Mexico Immunity Boosting Products Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Distribution Channel

7. Europe Immunity Boosting Products Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Distribution Channel
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Immunity Boosting Products Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Distribution Channel
    • 7.3.2. France Immunity Boosting Products Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Distribution Channel
    • 7.3.3. United Kingdom Immunity Boosting Products Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Distribution Channel
    • 7.3.4. Italy Immunity Boosting Products Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Distribution Channel
    • 7.3.5. Spain Immunity Boosting Products Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Distribution Channel

8. Asia Pacific Immunity Boosting Products Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Distribution Channel
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Immunity Boosting Products Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Distribution Channel
    • 8.3.2. India Immunity Boosting Products Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Distribution Channel
    • 8.3.3. Japan Immunity Boosting Products Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Distribution Channel
    • 8.3.4. South Korea Immunity Boosting Products Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Distribution Channel
    • 8.3.5. Australia Immunity Boosting Products Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Distribution Channel

9. Middle East & Africa Immunity Boosting Products Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Distribution Channel
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Immunity Boosting Products Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Distribution Channel
    • 9.3.2. UAE Immunity Boosting Products Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Distribution Channel
    • 9.3.3. South Africa Immunity Boosting Products Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Distribution Channel

10. South America Immunity Boosting Products Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Distribution Channel
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Immunity Boosting Products Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Distribution Channel
    • 10.3.2. Colombia Immunity Boosting Products Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Distribution Channel
    • 10.3.3. Argentina Immunity Boosting Products Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Immunity Boosting Products Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Amway Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Herbalife Nutrition Ltd.
  • 15.3. Nestle S.A.
  • 15.4. Pfizer Inc.
  • 15.5. Bayer AG
  • 15.6. NOW Foods
  • 15.7. Nature's Bounty Co.
  • 15.8. GNC Holdings, Inc.
  • 15.9. Himalaya Drug Company
  • 15.10. Glanbia plc

16. Strategic Recommendations

17. About Us & Disclaimer